All Articles

The ad tech giant adds a Google and LinkedIn veteran to its board, a calculated move to deepen its AI expertise and champion the open internet amid market headwinds.

With a new CMO, $50M in fresh capital, and pivotal trials on the horizon, Cue Biopharma makes a strategic bet on an immunology veteran to guide its future.

Lumen's new partnership with Palo Alto Networks leverages deep network intelligence to spot threats before they hit, aiming to end alert fatigue for security teams.

Octane names veteran Janelle Brunette its first female CEO, a move positioning the SoCal powerhouse for deeper impact and its next phase of strategic growth.

As solar tracker giant Array Technologies preps its Q2 results, we look beyond the numbers at the market forces and strategic shifts defining the industry.

While headlines focus on AI, Syntec Optics is quietly building the foundational hardware that gives soldiers superhuman vision. A look at the unseen progress.

The e-commerce giant reports a tripling of brand protection efforts. But do the impressive numbers translate to a safer marketplace for brands and consumers?

A massive concrete segment was hoisted over Bhopal, a milestone in the city's metro project. It's more than engineering; it's the future of urban life arriving.

A startup led by a former Marine Intel Officer just raised $4M. The deal signals a major shift in how venture capital views the future of work in construction.

We-Vibe and Adam & Eve are taking sexual wellness on the road. It's more than a marketing stunt; it's a look at the future of experiential retail.

Beyond the shower puff: Cleanlogic's new line embeds skincare into bath tools. But its exclusive Ulta launch is a masterclass in strategic growth.

Voyager Therapeutics' new gene therapy just cleared a key FDA hurdle. With promising preclinical data, it's a major momentum signal in the fight against Alzheimer's.

Qorvo’s recent honor from Northrop Grumman is more than a trophy. It’s a look into the vital, innovative supply chains that truly power global security.

A breakthrough study shows a wearable ear device can stimulate nerves to enhance the body’s natural clotting, offering a drug-free future for saving lives.

Alarum Technologies faces an existential threat after FBI seizures. With a third of its staff cut and no answers, the company's future hangs in the balance.

o9 Solutions' promotion of an insider as COO isn't a simple C-suite shuffle. It's a clear signal of its ambition to move beyond AI tech to redefine how companies operate.

After an initial rejection, Sydnexis's pediatric myopia drug gets a crucial FDA hearing, raising hopes for the first approved U.S. pharmaceutical treatment.

Kahuna Labs' new AI module analyzes support interactions to find hidden growth opportunities, transforming a reactive department into a strategic source of revenue.